Evaluation of everolimus (EVE) in HER2+advanced breast cancer (BC) with activated PI3K/mTOR pathway: Exploratory biomarker observations from the BOLERO-3 trial
dc.contributor.author | White, M. | |
dc.contributor.author | Gianni, L. | |
dc.contributor.author | Lang, I. | |
dc.contributor.author | Toi, M. | |
dc.contributor.author | Taran, T. | |
dc.contributor.author | Jerusalem, G. | |
dc.contributor.author | Andre, F. | |
dc.contributor.author | Chen, D. | |
dc.contributor.author | Robinson, D. | |
dc.contributor.author | Ozguroglu, M. | |
dc.date.accessioned | 2021-03-04T11:03:57Z | |
dc.date.available | 2021-03-04T11:03:57Z | |
dc.identifier.citation | Jerusalem G., Andre F., Chen D., Robinson D., Ozguroglu M., Lang I., White M., Toi M., Taran T., Gianni L., "Evaluation of everolimus (EVE) in HER2+advanced breast cancer (BC) with activated PI3K/mTOR pathway: Exploratory biomarker observations from the BOLERO-3 trial", EUROPEAN JOURNAL OF CANCER, cilt.49, 2013 | |
dc.identifier.issn | 0959-8049 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_706ad0be-5763-4e0a-ab01-74002ab3dfbd | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/77480 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Evaluation of everolimus (EVE) in HER2+advanced breast cancer (BC) with activated PI3K/mTOR pathway: Exploratory biomarker observations from the BOLERO-3 trial | |
dc.type | Makale | |
dc.relation.journal | EUROPEAN JOURNAL OF CANCER | |
dc.contributor.department | University of Liege , , | |
dc.identifier.volume | 49 | |
dc.contributor.firstauthorID | 210911 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Makale [92796]